scholarly article | Q13442814 |
P50 | author | Ruth Knüchel-Clarke | Q2177653 |
Edgar Dahl | Q30004394 | ||
Jürgen Veeck | Q30004422 | ||
Erik Noetzel | Q59685487 | ||
Arndt Hartmann | Q89782316 | ||
Nuran Bektas | Q117248893 | ||
P2093 | author name string | Edgar Jost | |
P2860 | cites work | Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling | Q22011203 |
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow | Q24291392 | ||
Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC | Q24291638 | ||
Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer | Q24293304 | ||
Comprehensive analysis of CpG islands in human chromosomes 21 and 22 | Q24531622 | ||
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells | Q27860717 | ||
Wnt signaling and cancer | Q27860871 | ||
Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites | Q28187720 | ||
The power and the promise of DNA methylation markers | Q28188233 | ||
Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: a possible mechanism of mammary tumorigenesis | Q28237570 | ||
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer | Q28251800 | ||
Methylation changes in faecal DNA: a marker for colorectal cancer screening? | Q28257322 | ||
Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer | Q28260824 | ||
Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma | Q28268844 | ||
Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions | Q28292507 | ||
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis | Q28294866 | ||
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection | Q28306755 | ||
Epigenetics in human disease and prospects for epigenetic therapy | Q29547437 | ||
Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
MethPrimer: designing primers for methylation PCRs | Q29618664 | ||
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer | Q33248745 | ||
Tumor suppressor genes: the puzzle and the promise | Q33360216 | ||
Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor | Q33867627 | ||
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer | Q34126908 | ||
Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome | Q34231008 | ||
Aberrant DNA methylation as a cancer-inducing mechanism | Q34410454 | ||
MGMT promoter methylation and field defect in sporadic colorectal cancer. | Q34452509 | ||
Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis | Q34763742 | ||
Secreted Frizzled-related proteins: searching for relationships and patterns | Q34811402 | ||
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression | Q35679187 | ||
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer | Q36510089 | ||
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma | Q36611455 | ||
DNA methylation in breast and colorectal cancers | Q36803766 | ||
Method for grading breast cancer | Q37232617 | ||
Comparison of features of human breast cancer cell lines and their corresponding tumors | Q38469971 | ||
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation | Q40102564 | ||
Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer | Q40171588 | ||
Biological differences among MCF-7 human breast cancer cell lines from different laboratories | Q42660326 | ||
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies | Q44646952 | ||
DNA methylation analysis by MethyLight technology | Q46134861 | ||
Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus | Q46433748 | ||
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. | Q46696080 | ||
CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia | Q46902022 | ||
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray. | Q47616131 | ||
Secreted frizzled-related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal mammary glands. | Q48004390 | ||
Secreted frizzled related protein 2 (sFRP2) decreases susceptibility to UV-induced apoptosis in primary culture of canine mammary gland tumors by NF-kappaB activation or JNK suppression. | Q51798920 | ||
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. | Q53335862 | ||
High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. | Q53349508 | ||
Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue | Q57591075 | ||
Cyclin D1 protein expression and function in human breast cancer | Q58883578 | ||
Epigenetic Inactivation of SFRP Genes and TP53 Alteration Act Jointly as Markers of Invasive Bladder Cancer | Q59313166 | ||
[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue] | Q68175965 | ||
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers | Q71729088 | ||
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas | Q71804951 | ||
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells | Q72386166 | ||
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments] | Q73368658 | ||
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer | Q74088944 | ||
Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype | Q78532817 | ||
SFRP2 methylation in fecal DNA--a marker for colorectal polyps | Q80637295 | ||
Methylation-specific polymerase chain reaction | Q81872282 | ||
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort | Q82843914 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
hypermethylation | Q106875739 | ||
P304 | page(s) | 83 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Molecular Cancer | Q15724585 |
P1476 | title | Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer | |
P478 | volume | 7 |